Statins: an essential component in the management of carotid artery disease
- PMID: 17664116
- DOI: 10.1016/j.jvs.2007.03.035
Statins: an essential component in the management of carotid artery disease
Abstract
Objective: We aimed to define the role of treatment using statins (3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors) in the management of patients with carotid artery disease.
Literature search methods: We searched PubMed for studies evaluating the effect of statins on carotid IMT and the occurrence of cerebrovascular events.
Literature search results: Current evidence indicates that routine statin therapy reduces carotid intima-media thickness progression and stroke risk. Additionally, statin treatment significantly reduces perioperative as well as long-term morbidity and mortality in patients undergoing carotid surgery or endovascular interventions. It would also be expected that statins would reduce coronary events in this high-risk population.
Conclusions: Statins should be considered as an essential component of the therapeutic approach of patients with carotid artery stenosis.
Similar articles
-
Is carotid intima-media thickness a reliable clinical predictor?Mayo Clin Proc. 2008 Nov;83(11):1299-300; author reply 1300-1. doi: 10.4065/83.11.1299. Mayo Clin Proc. 2008. PMID: 18990332 No abstract available.
-
The effect of pravastatin on intima media thickness of the carotid artery in patients with normal cholesterol.Eur J Vasc Endovasc Surg. 2005 Nov;30(5):464-8. doi: 10.1016/j.ejvs.2005.05.007. Eur J Vasc Endovasc Surg. 2005. PMID: 16099694 Clinical Trial.
-
Statins and stroke prevention.Cerebrovasc Dis. 2007;24(2-3):170-82. doi: 10.1159/000104474. Epub 2007 Jun 27. Cerebrovasc Dis. 2007. PMID: 17596685 Review.
-
3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors reduce the risk of perioperative stroke and mortality after carotid endarterectomy.J Vasc Surg. 2005 Nov;42(5):829-36; discussion 836-7. doi: 10.1016/j.jvs.2005.08.039. J Vasc Surg. 2005. PMID: 16275430
-
The effect of statin medications on perioperative and long-term outcomes following carotid endarterectomy or stenting.Semin Vasc Surg. 2007 Dec;20(4):252-8. doi: 10.1053/j.semvascsurg.2007.10.008. Semin Vasc Surg. 2007. PMID: 18082842 Review.
Cited by
-
Statin therapy in peritoneal dialysis patients: effects beyond lipid lowering.Int Urol Nephrol. 2008;40(1):165-70. doi: 10.1007/s11255-007-9307-6. Epub 2007 Dec 8. Int Urol Nephrol. 2008. PMID: 18066677 Review.
-
Risk Factors for Silent Lacunar Infarction in Patients with Transient Ischemic Attack.Med Sci Monit. 2016 Feb 11;22:447-53. doi: 10.12659/msm.895759. Med Sci Monit. 2016. PMID: 26864634 Free PMC article.
-
Hypoglycemia does not affect the progression of preclinical atherosclerosis in subjects with type 2 diabetes.PLoS One. 2019 Mar 5;14(3):e0212871. doi: 10.1371/journal.pone.0212871. eCollection 2019. PLoS One. 2019. PMID: 30835778 Free PMC article.
-
What are the benefits and drawbacks of statins in carotid artery disease? A perspective review.Expert Rev Cardiovasc Ther. 2023 Jul-Dec;21(11):763-777. doi: 10.1080/14779072.2023.2286011. Epub 2023 Dec 10. Expert Rev Cardiovasc Ther. 2023. PMID: 37994875 Free PMC article. Review.
-
Do the Effects of Secondary Prevention of Cardiovascular Events in PAD Patients Differ from Other Atherosclerotic Disease?Int J Mol Sci. 2015 Jun 25;16(7):14477-89. doi: 10.3390/ijms160714477. Int J Mol Sci. 2015. PMID: 26121301 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical